» Articles » PMID: 37623662

Liver DECM-Gelatin Composite Bioink for Precise 3D Printing of Highly Functional Liver Tissues

Overview
Date 2023 Aug 25
PMID 37623662
Authors
Affiliations
Soon will be listed here.
Abstract

In recent studies, liver decellularized extracellular matrix (dECM)-based bioinks have gained significant attention for their excellent compatibility with hepatocytes. However, their low printability limits the fabrication of highly functional liver tissue. In this study, a new liver dECM-gelatin composite bioink (dECM gBioink) was developed to overcome this limitation. The dECM gBioink was prepared by incorporating a viscous gelatin mixture into the liver dECM material. The novel dECM gBioink showed 2.44 and 10.71 times higher bioprinting resolution and compressive modulus, respectively, than a traditional dECM bioink. In addition, the new bioink enabled stable stacking with 20 or more layers, whereas a structure printed with the traditional dECM bioink collapsed. Moreover, the proposed dECM gBioink exhibited excellent hepatocyte and endothelial cell compatibility. At last, the liver lobule mimetic structure was successfully fabricated with a precisely patterned endothelial cell cord-like pattern and primary hepatocytes using the dECM gBioink. The fabricated lobule structure exhibited excellent hepatic functionalities and dose-dependent responses to hepatotoxic drugs. These results demonstrated that the gelatin mixture can significantly improve the printability and mechanical properties of the liver dECM materials while maintaining good cytocompatibility. This novel liver dECM gBioink with enhanced 3D printability and resolution can be used as an advanced tool for engineering highly functional liver tissues.

Citing Articles

Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment.

Ciftci F, Ozarslan A, Kantarci I, Yelkenci A, Tavukcuoglu O, Ghorbanpour M Pharmaceutics. 2025; 17(1).

PMID: 39861768 PMC: 11769154. DOI: 10.3390/pharmaceutics17010121.


Photocrosslinkable Biomaterials for 3D Bioprinting: Mechanisms, Recent Advances, and Future Prospects.

Lai Y, Xiao X, Huang Z, Duan H, Yang L, Yang Y Int J Mol Sci. 2024; 25(23).

PMID: 39684279 PMC: 11641133. DOI: 10.3390/ijms252312567.


3D Bioprinting for Engineered Tissue Constructs and Patient-Specific Models: Current Progress and Prospects in Clinical Applications.

Lee S, Jeong W, Atala A Adv Mater. 2024; 36(49):e2408032.

PMID: 39420757 PMC: 11875024. DOI: 10.1002/adma.202408032.


Decellularized extracellular matrix-based disease models for drug screening.

Chen Z, Wang J, Kankala R, Jiang M, Long L, Li W Mater Today Bio. 2024; 29:101280.

PMID: 39399243 PMC: 11470555. DOI: 10.1016/j.mtbio.2024.101280.


The Prospect of Hepatic Decellularized Extracellular Matrix as a Bioink for Liver 3D Bioprinting.

Shi W, Zhang Z, Wang X Biomolecules. 2024; 14(8).

PMID: 39199406 PMC: 11352484. DOI: 10.3390/biom14081019.


References
1.
Jeong W, Kim M, Kang H . Effect of detergent type on the performance of liver decellularized extracellular matrix-based bio-inks. J Tissue Eng. 2021; 12:2041731421997091. PMC: 7919203. DOI: 10.1177/2041731421997091. View

2.
Chae S, Sun Y, Choi Y, Ha D, Jeon I, Cho D . 3D cell-printing of tendon-bone interface using tissue-derived extracellular matrix bioinks for chronic rotator cuff repair. Biofabrication. 2020; 13(3). DOI: 10.1088/1758-5090/abd159. View

3.
Das S, Kim S, Choi Y, Lee S, Lee S, Kong J . Decellularized extracellular matrix bioinks and the external stimuli to enhance cardiac tissue development in vitro. Acta Biomater. 2019; 95:188-200. DOI: 10.1016/j.actbio.2019.04.026. View

4.
Miyakawa K, Albee R, Letzig L, Lehner A, Scott M, Buchweitz J . A Cytochrome P450-Independent Mechanism of Acetaminophen-Induced Injury in Cultured Mouse Hepatocytes. J Pharmacol Exp Ther. 2015; 354(2):230-7. PMC: 4518070. DOI: 10.1124/jpet.115.223537. View

5.
Jin R, Cui Y, Chen H, Zhang Z, Weng T, Xia S . Three-dimensional bioprinting of a full-thickness functional skin model using acellular dermal matrix and gelatin methacrylamide bioink. Acta Biomater. 2021; 131:248-261. DOI: 10.1016/j.actbio.2021.07.012. View